CD8A and neoplasm: These molecules reprogram immune cells into tumor-supportive phenotypes, such as TAMs, Tregs, and myeloid-derived suppressor cells (MDSCs), impairing the cytotoxic activity of NK and CD8+ T cells [106,107,186].